Founded
Address
Intersouth Partners
406 Blackwell Street
Suite 200
Durham, NC 27701
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30062
Company type
Venture capital firm based in Durham, North Carolina.Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Intersouth Partners V | 2000 | USD | 175,000,000 | |
| Intersouth Partners IV | 1998 | USD | 65,000,000 | |
| Intersouth Partners II | ||||
| Intersouth Partners III |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 94| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Accordant Health Services Inc | N/A | ||||
|
|
Applied Genetic Technologies Corp | A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. | N/A | |||
|
|
Argolyn Bioscience Inc | Peptide drug developer. | N/A | |||
|
|
Argos Therapeutics Inc | Series D | ||||
|
|
Argos Therapeutics Inc | Series C | ||||
|
|
Argos Therapeutics Inc | Series B | ||||
|
|
Argos Therapeutics Inc | Series A | ||||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series D | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series C | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series B | |||
|
|
Athenix Corp | Athenix Corp. is a privately held biotechnology company. | Series A | |||
|
|
Bright Hub Inc | An “expert” content web business, combined with proprietary tools to enable inexpensive creation and aggregation of expert content and additional soft | N/A | |||
|
|
Burl Software | N/A | ||||
|
|
Calibra Medical Inc | A medical device company developing a unique, wearable three-day insulin patch. | N/A | |||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
Cempra Inc | Developer of a drugs for difficult-to-treat and drug-resistant bacterial infections. | N/A | |||
|
|
Clarabridge | A text analytics software company that provides customer experience management (CEM) solutions | Series C | |||
|
|
Clarabridge | A text analytics software company that provides customer experience management (CEM) solutions | Series B | |||
|
|
Comstock Systems Corp | N/A | ||||
|
|
Covega Corp | Components and integrated-optic subsystems. | N/A | |||
|
|
Covelight Systems | N/A | ||||
|
|
CSA Medical Inc | CSA Medical has advanced the proven science of cryotherapy. | N/A | |||
|
|
Digital Optics Corp | N/A | ||||
|
|
Encelle Inc | Life sciences company developing novel products for regenerative medicine. | N/A | |||
|
|
Extensibility | Provided cutting-edge XML schema development, conversion and management solutions in order to facilitate the transition of traditional applications. | N/A |
Team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Garheng Kong | Sofinnova Ventures Inc | |||
| David Pierson | Syngenta Group Ventures | Managing Director
Durham |